En Es
Categories

Industry News


Siemens to List Siemens Healthineers on Frankfurt Stock Exchange

By HospiMedica International staff writers
06 Dec 2017

Image: Siemens AG is preparing to list its separately managed healthcare unit, Siemens Healthineers on the Prime Standard segment of the Frankfurt Stock Exchange's Regulated Market (Photo courtesy of Siemens).Siemens AG (Munich, Germany; Munich), a provider of medical imaging and laboratory diagnostics equipment, is preparing to list its separately managed healthcare unit, Siemens Healthineers (Erlangen, Germany), on the Prime Standard segment of the Frankfurt Stock Exchange's Regulated Market. The move was approved at a meeting by the company's Supervisory Board and has been planned for the first half of 2018. Siemens Healthineers AG will be established for the public listing.

"For Siemens Healthineers, the public listing is the next logical step and the foundation for expanding our strong position as a leading global supplier of healthcare technology," said Michael Sen, Chairman of the Siemens Healthineers Supervisory Board and the member of Siemens' Managing Board responsible, among other things, for healthcare technology. "Frankfurt is one of the world's largest trading centers for securities, and its importance will continue to increase due to Brexit. As a highly liquid trading venue, Frankfurt is attractive for investors from around the world. The public listing will give Siemens Healthineers entrepreneurial flexibility and access to the capital market. The goal is to grow sustainably and profitably while actively shaping the paradigm shift in the healthcare industry."

"Our preparations for the public listing are completely on schedule. The Strategy 2025 concept and the management team are in place. The legal prerequisites have largely been fulfilled," said Siemens Chief Financial Officer Ralf P. Thomas. "Deutsche Bank, Goldman Sachs International and J.P. Morgan have been engaged as global coordinators, and BNP PARIBAS, BofA Merrill Lynch, Citigroup and UBS Investment Bank as further syndicate banks."



E-mail Print
FaceBook Twitter Google+ Linked in

Siemens Healthineers

Provides customized electronic systems and advanced imaging, diagnostics, therapy, and healthcare IT solutions for the medical industry
More info

More articles about Siemens Healthineers

07 Nov 2017
Siemens Healthineers Closes Epocal Acquisition
Siemens Healthineers, the separately managed healthcare business of Siemens AG, has completed the acquisition of Epocal Inc., a subsidiary of Alere Inc. that develops and provides point-of-care (POC) blood diagnostic systems for healthcare enterprises.
Read More
16 Oct 2017
Siemens Healthineers Enters Agreement with HORIBA Medical
Siemens Healthineers and HORIBA Medical have entered into a long-term agreement to bring new and innovative hematology solutions to the market globally.
Read More
24 Jul 2017
Siemens to Acquire Blood Gas Subsidiary of Alere
Siemens Healthineers, the separately managed healthcare business of Siemens AG, has entered into a definitive agreement to acquire Epocal Inc., a subsidiary of Alere Inc. that develops and provides point-of-care (POC) blood diagnostic systems for healthcare enterprises.
Read More
28 Jun 2017
Alliance Formed to Digitalize Medicine and Healthcare
The Universitätsklinikum Erlangen, Siemens Healthineers (Erlangen, Germany), the Friedrich-Alexander-Universität-Erlangen-Nürnberg (FAU), the Fraunhofer Institute for Integrated Circuits (IIS), and Medical Valley EMN have entered into an alliance to establish the Digital Health Innovation Platform (d.hip) with the aim of driving digitalization in medicine and healthcare.
Read More
14 Jun 2017
Siemens Healthineers and Fast-track Diagnostics Form Strategic Relationship
Siemens Healthineers, the separately managed healthcare business of Siemens AG, has entered into a new strategic relationship with Fast-track Diagnostics for the addition of FTD’s broad range of CE-marked kits and multi-syndromic panels to the menu of Siemens Healthineers’ VERSANT kPCR Molecular System. This will allow Siemens Healthineers to provide its customers with expanded, more comprehensive molecular testing solutions.
Read More
26 Apr 2017
Siemens Healthineers Acquires Medicalis to Expand PHM Portfolio
Siemens Healthineers has signed an agreement to acquire Medicalis Corporation with the aim of expanding its Population Health Management (PHM) portfolio.
Read More
25 Apr 2017
Siemens Healthineers Partners with Ebit to Improve Workflow Efficiency
Siemens Healthineers has partnered with Ebit Srl-Esaote Group, dedicated to healthcare IT, to resell Ebit’s Suitestensa cardiovascular information system (CVIS) as an option with all its cardiology systems throughout Germany.
Read More
21 Feb 2017
Siemens Healthineers Announces Digital Platform for Healthcare Providers
Siemens Healthineers announced a digital platform for healthcare providers as well as for providers of solutions and services, at the Health IT Conference (HIMSS) 2017 in Orlando. The platform, covering the entire spectrum of healthcare, is meant to foster the growth of a digital ecosystem that links healthcare providers and solution providers with each other, as well as brings together their data, applications and services.
Read More

Additional news

12 Dec 2017
TeraRecon to Sell EnvoyAI Platform
TeraRecon, a provider of advanced visualization solutions, has entered into a distribution partnership with EnvoyAI to sell and market the EnvoyAI platform. The platform includes a content-rich artificial intelligence (AI) marketplace, called the EnvoyAI Exchange, as well as a suite of market-ready AI-enablement technologies aimed at fostering broader access and clinical use of medical imaging algorithms within busy radiology practices.
Read More
12 Dec 2017
Google Releases AI Tool for Precision Medicine
Google LLC has announced the open source release of DeepVariant, a deep learning technology to reconstruct the true genome sequence from high-throughput sequencing (HTS) data with significantly greater accuracy than previous classical methods. DeepVariant, which was developed after more than two years of research by the Google Brain team, in collaboration with Verily Life Sciences, transforms the task of variant calling, as this reconstruction problem is known in genomics, into an image classification problem well-suited to Google's existing technology and expertise. Within a year of its development, the deep learning model had won the 2016 PrecisionFDA Truth Challenge award for Highest SNP Performance, outperforming state-of-the-art methods. Since then, the Google Brain team has reduced the error rate by over 50%.
Read More
11 Dec 2017
Esaote to Be Acquired by Consortium of Chinese Healthcare Companies
Esaote S.p.A. has entered into definitive agreements with a consortium of Chinese investors who will acquire the entire share capital of the company. The consortium acquiring Esaote comprises leading medical technology and healthcare companies, as well as financial investors with significant experience in the healthcare sector.
Read More
06 Dec 2017
Global Hybrid OR Market to Reach USD 1,17 Million by 2022
The global hybrid operating room (OR) market is expected to grow at a CAGR of 12.5% from USD 652.0 million in 2017 to USD 1,174.9 million by 2022, driven by technological advancements in robot-assisted surgeries, increasing minimally invasive surgeries, and growing patient preference for affordable & effective surgical treatments. However, high establishment costs and procedural risks for patients associated with hybrid ORs are expected to limit the market growth during 2017 to 2022.
Read More
06 Dec 2017
GE Healthcare and Nuance Partner with NVIDIA to Bring AI to Medical Imaging
Healthcare-solution providers GE Healthcare and Nuance Communications, Inc., have partnered with NVIDIA, a leader in visual computing technologies, for using the company’s deep learning platform to bring Artificial Intelligence (AI) to medical imaging.
Read More
06 Dec 2017
Neuroimaging Platform Uses 3D AI to Offer Brain Visualization
QMENTA, a medical image storage, processing and visualization company focused on brain data analysis, specifically using MRI and related clinical data, has developed a cloud-based system for neuroimages and all related data, with data management, analysis and visualization capabilities.
Read More
05 Dec 2017
GE Launches Drawbridge Health to Transform Blood Collection
GE Healthcare has introduced Drawbridge Health, a privately held healthcare technology company, which is developing a people-friendly system to integrate draw, collection and stabilize blood samples into a single device. The technology which integrates engineering and proprietary chemistries is also being developed to support room temperature shipping and streamlined downstream processing, thus ensuring reliable, accurate results.
Read More
29 Nov 2017
CE Mark Awarded to First Commercial Head And Neck Deep Learning Solution
The world's first commercial head and neck deep learning medical imaging solution from Aidoc, an AI startup utilizing deep learning to augment radiologists' workflow and highlight anomalous cases, has received CE (Conformité Européenne) marking, allowing for its widespread commercialization in Europe.
Read More
28 Nov 2017
Global Surgical Imaging Market to Reach USD 1.63 Billion by 2022
The global surgical imaging market is projected to grow at a CAGR of 5.5% from an estimated value of USD 1.25 billion in 2017 to USD 1.63 billion by 2022, driven mainly by the growing popularity of Flat Panel Detector C-arms (FPD C-arms) owing to the advantages of FPDs over image intensifiers, reimbursement cuts on analog radiography systems, and rising demand for minimally invasive procedures.
Read More
Copyright © 2000-2017 TradeMed.com. All rights reserved. | Terms And Conditions